Hypogonadism in male outpatients with sarcoidosis.

[1]  W. Wodzig,et al.  ACE I/D-corrected Z-scores to identify normal and elevated ACE activity in sarcoidosis. , 2007, Respiratory medicine.

[2]  S. Sorichter,et al.  Impact of impaired inspiratory muscle strength on dyspnea and walking capacity in sarcoidosis. , 2006, Chest.

[3]  M. Dalinka.  MRI of Sarcoidosis Patients With Musculoskeletal Symptoms , 2006 .

[4]  G. Verleden,et al.  Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.

[5]  M. Decramer,et al.  Psychosocial conditions do not affect short-term outcome of multidisciplinary rehabilitation in chronic obstructive pulmonary disease. , 2005, Archives of physical medicine and rehabilitation.

[6]  M. Tobin,et al.  Hypogonadism in men with chronic obstructive pulmonary disease: prevalence and quality of life. , 2005, American journal of respiratory and critical care medicine.

[7]  Shalender Bhasin,et al.  Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. , 2005, The Journal of clinical endocrinology and metabolism.

[8]  R. Gosselink,et al.  Rehabilitation programmes in sarcoidosis: a multidisciplinary approach , 2005 .

[9]  M. Decramer,et al.  Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status , 2004, Thorax.

[10]  R. Neviere,et al.  Clinical impact of inspiratory muscle impairment in sarcoidosis. , 2004, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[11]  M. Mishima,et al.  Diabetes insipidus from neurosarcoidosis: long-term follow-up for more than eight years. , 2004, Internal medicine.

[12]  E. Hoitsma,et al.  Neurosarcoidosis: a clinical dilemma , 2004, The Lancet Neurology.

[13]  S. Sorichter,et al.  Peak or plateau maximal inspiratory mouth pressure: which is best? , 2004, European Respiratory Journal.

[14]  G. Cavallini,et al.  Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging. , 2004, Urology.

[15]  Thierry Troosters,et al.  Exercise training during rehabilitation of patients with COPD: a current perspective. , 2004, Patient education and counseling.

[16]  Cynthia D. Brown,et al.  Health-related quality of life of persons with sarcoidosis. , 2004, Chest.

[17]  B. Felker,et al.  Increased incidence of diagnosed depressive illness in hypogonadal older men. , 2004, Archives of general psychiatry.

[18]  A. Morgentaler,et al.  Risks of testosterone-replacement therapy and recommendations for monitoring. , 2004, The New England journal of medicine.

[19]  R. Casaburi,et al.  Endocrinological disturbances in chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[20]  C. Gallagher,et al.  Corticosteroids and skeletal muscle function in cystic fibrosis. , 2003, Journal of applied physiology.

[21]  M. Decramer,et al.  CHRONIC OBSTRUCTIVE PULMONARY DISEASE Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I , 2003 .

[22]  S. Seidman.  The aging male: androgens, erectile dysfunction, and depression. , 2003, The Journal of clinical psychiatry.

[23]  F. Maltais,et al.  Catabolic/anabolic balance and muscle wasting in patients with COPD. , 2003, Chest.

[24]  M. Schlaak,et al.  Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis , 2003, European Respiratory Journal.

[25]  R. Adler,et al.  Glucocorticoid-Induced Osteoporosis in Patients with Sarcoidosis , 2003, The American journal of the medical sciences.

[26]  J. Ware.  SF-36 health survey: Manual and interpretation guide , 2003 .

[27]  M. Decramer,et al.  Resistance versus endurance training in patients with COPD and peripheral muscle weakness , 2002, European Respiratory Journal.

[28]  K. Schulz,et al.  Descriptive studies: what they can and cannot do , 2002, The Lancet.

[29]  G. McLennan,et al.  Clinical characteristics of patients in a case control study of sarcoidosis. , 2001, American journal of respiratory and critical care medicine.

[30]  B. Ursø,et al.  Oral creatine supplementation facilitates the rehabilitation of disuse atrophy and alters the expression of muscle myogenic factors in humans , 2001, The Journal of physiology.

[31]  J. Bavaria,et al.  Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. , 2001, Chest.

[32]  A. Baydur,et al.  Respiratory muscle strength, lung function, and dyspnea in patients with sarcoidosis. , 2001, Chest.

[33]  G. Newshan,et al.  The use of anabolic agents in HIV disease , 2001, International journal of STD & AIDS.

[34]  C. Rand,et al.  Depression in sarcoidosis. , 2001, American journal of respiratory and critical care medicine.

[35]  J. Rabkin,et al.  A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms. , 2000, Archives of general psychiatry.

[36]  T. Lue.  Erectile dysfunction. , 2000, The New England journal of medicine.

[37]  G. Raghu,et al.  Assessment of health-related quality of life in patients with interstitial lung disease. , 1999, Chest.

[38]  M. Decramer,et al.  Six minute walking distance in healthy elderly subjects. , 1999, The European respiratory journal.

[39]  L. Carbone,et al.  Recurrent fainting, dysesthesia, and impotence. , 1999, Hospital practice.

[40]  S. Davis,et al.  Androgen replacement in women: a commentary. , 1999, The Journal of clinical endocrinology and metabolism.

[41]  E. Wouters,et al.  Association of fatigue with an acute phase response in sarcoidosis. , 1999, The European respiratory journal.

[42]  J. Rabkin,et al.  Testosterone as a treatment for fatigue in HIV+ men. , 1998, General hospital psychiatry.

[43]  T. Perneger.  What's wrong with Bonferroni adjustments , 1998, BMJ.

[44]  H. Magnussen,et al.  Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. , 1998, The European respiratory journal.

[45]  E. Wouters,et al.  Quality of life and depressive symptoms in patients suffering from sarcoidosis. , 1998, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[46]  E. Wouters,et al.  Relationship between respiratory muscle function and quality of life in sarcoidosis. , 1997, The European respiratory journal.

[47]  Sharma Op,et al.  Intrascrotal sarcoidosis: case reports and review. , 1996 .

[48]  M. Decramer,et al.  Corticosteroids contribute to muscle weakness in chronic airflow obstruction. , 1994, American journal of respiratory and critical care medicine.

[49]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[50]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[51]  H. Nyborg,et al.  Racial/ethnic variations in male testosterone levels: A probable contributor to group differences in health , 1992, Steroids.

[52]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[53]  T. Pigott,et al.  Depression and sexual dysfunction complicating neurosarcoidosis. , 1987, Journal of the South Carolina Medical Association.

[54]  H. Wokalek,et al.  [Disorders of potency caused by sarcoidosis]. , 1985, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[55]  R. Snaith,et al.  The hospital anxiety and depression scale. , 2013, Acta psychiatrica Scandinavica.

[56]  M. Gardner,et al.  Statistical guidelines for contributors to medical journals. , 1983, British medical journal.

[57]  D. F. Rochester,et al.  Respiratory muscle failure. , 1983, The Medical clinics of North America.

[58]  J. Scadding.  Prognosis of Intrathoracic Sarcoidosis in England , 1961, British medical journal.